Magovern G J, Golding L A, Oyer P E, Cabrol C
Ann Thorac Surg. 1989 Jan;47(1):102-7. doi: 10.1016/0003-4975(89)90249-x.
After a patient has been supported with a circulatory assist device, the expected outcomes are weaning, bridging, or discontinuation of support. An early insertion of the device will avoid deterioration of the heart and other organs to an irreversible condition. Cardiac assistance for a minimum of 24 hours is recommended with a mild dose of anticoagulant. It is necessary to monitor the hemodynamic functions during circulatory support and weaning. Most of the mechanical devices are quite reliable, and complications during ventricular assist are easily managed. The patient should be in the same condition as in ordinary elective transplant candidate before transplantation. Patients with an artificial heart or ventricular assist device should not be on the priority emergency list for cardiac transplantation. Patients suffering from cardiogenic shock can be stabilized with a ventricular assist device to allow the heart to recover or be provided with other treatment. A circulatory support device can also be used as a bridge for patients awaiting a cardiac transplant.
在患者接受循环辅助装置支持后，预期结果是撤机、过渡或停止支持。尽早植入该装置可避免心脏和其他器官恶化至不可逆状态。建议使用小剂量抗凝剂，心脏辅助至少24小时。在循环支持和撤机过程中监测血流动力学功能很有必要。大多数机械设备相当可靠，心室辅助期间的并发症易于处理。移植前，患者应处于与普通择期移植候选者相同的状态。植入人工心脏或心室辅助装置的患者不应列入心脏移植优先紧急名单。患有心源性休克的患者可通过心室辅助装置稳定病情，使心脏恢复或接受其他治疗。循环支持装置也可作为等待心脏移植患者的过渡手段。
